Skip to content
Recall Observatory FDA recall evidence

Device product

Accula SARS-CoV-2 Test, REF: COV4100

Z-1009-2022

April 06, 2022

Class I

Product summary

Firm
MESA BIOTECH, INC
Event
Event 90013
Status
Ongoing
Classification
Class I
Quantity
6162
Official record key
device-enforcement:Z-1009-2022

Official wording

Reason: SARS-CoV-2 Test has an increased potential for false positive results, which may lead to a delay in correct diagnosis and treatment.

Code information: UDI/DI: B540COV41000; P22006-026, P22010-021, P22024-023, P22024-030, P22026-006, P22026-012, P22026-016 , P22010-001, P22010-030, P22024-026, P22024-032, P22026-007, P22026-013, P22026-017 , P22010-017, P22010-032, P22024-027, P22026-002, P22026-008, P22026-014, P22026-019 , P22010-019, P22024-021, P22024-028, P22026-004, P22026-009, P22026-015, P22032-011

Distribution pattern: US Nationwide distribution in the states of CA, TX, MA, NY, FL, NC, NJ, GA, CO, HI, PA, WA, NY, VA, MD, KY, WI, IL, PR, ND, MI, TN, AZ, UT.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    SARS-CoV-2 Test has an increased potential for false positive results, which may lead to a delay in correct diagnosis and treatment.